Actively Recruiting

Age: 0Years - 90Years
All Genders
Healthy Volunteers
ID06791473

AI-Based Cancer Diagnosis and Prediction Using Electronic Health Records

Led by The Eye Hospital of Wenzhou Medical University · Updated on 2025-07-30

1000000

Participants Needed

7

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate an AI-assisted predictive model designed to identify and diagnose cancer by using a wide range of health data. It focuses on early cancer detection to improve patient outcomes and survival rates, integrating medical history, lab results, imaging scans, and genetic markers. The study builds on a previous phase that analyzed data from around one million cancer patients to develop initial models. The current phase is a prospective, multi-center observational study launched in February 2025. It involves two groups: a healthy cohort without diagnosed cancer serving as a control group, and a tumor cohort of individuals diagnosed with various cancers. The AI system uses deep learning to analyze multimodal data from electronic health records, lab tests, imaging, and genetics to predict cancer risk and improve diagnostic accuracy. Participants will provide comprehensive health records including medical history and test results. Researchers will measure outcomes such as diagnostic accuracy using Area Under the Curve (AUC) and F1 Score over one year. Secondary outcomes include sensitivity and specificity of cancer detection. The study does not involve treatment but observes and compares data from both groups to validate the AI model's effectiveness in real-world clinical settings.

CONDITIONS

Brief Title

AI-Driven Cancer Diagnosis and Prediction With EHR

Who Can Participate

Age: 0Years - 90Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with comprehensive electronic health records, including medical history, laboratory results, imaging data, and genetic data if available
  • Individuals without severe cognitive impairments or conditions preventing informed consent or participation
  • Parents or guardians must provide consent for minors; adults must consent for themselves
Not Eligible

You will not qualify if you...

  • Patients with incomplete or missing key electronic health record data or insufficient follow-up
  • Individuals with severe cognitive disorders or terminal illnesses preventing meaningful participation
  • Pregnant women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote) for eligibility assessment

Diagnostic Evaluation

Duration - Up to 1 year

Participants undergo evaluation using an AI-based diagnostic system that analyzes their electronic health records, imaging, laboratory, and genetic data to predict cancer risk and support early detection.

Data are collected from existing electronic health records without additional visits

Long-term Monitoring

Duration - Up to 1 year

Participants are observed over time to monitor cancer outcomes and the effectiveness of the AI-assisted prediction model in a real-world clinical setting.

Ongoing observation through routine healthcare data; no additional visits required

Trial Site Locations

Total: 7 locations

1

Guangzhou Women and Children's Medical Center

Guangzhou, Guangdong, China

Actively Recruiting

2

Nanfang Hospital

Guangzhou, Guangdong, China

Actively Recruiting

3

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

Guangzhou, Guangdong, China

Actively Recruiting

4

Sun Yat-sen University Cancer Hospital

Guangzhou, Guangdong, China

Actively Recruiting

5

West China Hospital

Chengdu, Sichuan, China

Actively Recruiting

6

First Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China

Actively Recruiting

7

Second Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China

Actively Recruiting

Loading map...

Research Team

F

Fei Liu, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here